Equity Profile

COR

Cencora, Inc.

Health CareHealth Care Distributors$53.5B

Feb3Thu

Pre-Earnings Brief

UpcomingQ3-2026Pre-Market9:00 AM EST

Company Snapshot

Cencora, Inc. is a healthcare distributor that plays a crucial role in delivering medical products and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help gauge its financial health this quarter.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand in the healthcare sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Cencora, Inc. is a healthcare distributor that plays a crucial role in delivering medical products and services. With a market cap of $54 billion, the company is positioned in a sector that is increasingly focused on efficiency and innovation in healthcare delivery.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

In Q2-2026, Cencora reported an EPS of $4.75, slightly below expectations, which led to a significant drop in stock price the following day. The company has shown a mixed performance in previous quarters, with a tendency to surprise on the upside.

Management Promises & Guidance

Focus on improving operational efficiency.
Commitment to expanding product offerings.
Plans to enhance customer service and delivery capabilities.

Expectations

Wall Street Expectations

Overall, expectations for Cencora's upcoming earnings are cautious due to recent performance trends. Investors are looking for signs of recovery in profitability and revenue growth.

Bull Case

If Cencora can exceed EPS expectations and demonstrate strong revenue growth, it could signal a turnaround in performance and boost investor confidence.

Bear Case

Conversely, if the company misses on EPS and shows weak revenue growth, it could lead to further declines in stock price, reflecting ongoing concerns about its operational efficiency.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter?

Given the company's recent performance, a strong EPS could indicate a recovery, while a miss could further erode investor confidence.

How is revenue growth tracking compared to previous quarters?

Revenue growth is critical for assessing the company's market position and ability to meet demand in the healthcare sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cencora's ability to rebound from recent earnings misses, as historical trends show a strong recovery potential following similar setups.

Supporting Evidence

The options market is pricing a smaller move than historical averages, indicating a potential mispricing of volatility.

Cencora has a high EPS beat rate of 88%, suggesting a strong likelihood of exceeding expectations.

Recent operational improvements may not be fully reflected in current market sentiment.

Key Risk

If the EPS comes in above $4.85, it could significantly shift market sentiment in favor of the company.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal for Cencora, as it seeks to regain investor trust after recent earnings misses.

Bull Confirmed If

An EPS of $4.85 or higher would confirm the bull case and suggest a strong recovery in profitability.

Bear Confirmed If

An EPS below $4.50 would confirm the bear case and raise concerns about ongoing operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing a relatively small move in the stock, suggesting that investors are uncertain about significant changes in either direction.

Options are pricing a 0.94% move while the stock has averaged a 5.6% move historically, indicating a potentially undervalued setup.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing cheap setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

History suggests that if Cencora beats EPS expectations, the stock could rise by an average of +0.61%, confirming a positive turnaround.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting ongoing uncertainty about future growth.

Miss

If the company misses expectations, history indicates a potential drop of -17.38%, signaling deeper concerns about its operational efficiency.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Details on revenue growth in key segments.
3Management's outlook on market conditions and competitive landscape.
4Insights into customer demand trends and product offerings.
5Comments on cost management strategies and margin expectations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Cirrus Logic, Inc.

Company Snapshot

Cencora, Inc. is a healthcare distributor that plays a crucial role in delivering medical products and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help gauge its financial health this quarter.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand in the healthcare sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

Management Promises & Guidance

Focus on improving operational efficiency.
Commitment to expanding product offerings.
Plans to enhance customer service and delivery capabilities.

Expectations

Wall Street Expectations

Overall, expectations for Cencora's upcoming earnings are cautious due to recent performance trends. Investors are looking for signs of recovery in profitability and revenue growth.

Bull Case

If Cencora can exceed EPS expectations and demonstrate strong revenue growth, it could signal a turnaround in performance and boost investor confidence.

Bear Case

Conversely, if the company misses on EPS and shows weak revenue growth, it could lead to further declines in stock price, reflecting ongoing concerns about its operational efficiency.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter?

Given the company's recent performance, a strong EPS could indicate a recovery, while a miss could further erode investor confidence.

How is revenue growth tracking compared to previous quarters?

Revenue growth is critical for assessing the company's market position and ability to meet demand in the healthcare sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cencora's ability to rebound from recent earnings misses, as historical trends show a strong recovery potential following similar setups.

Supporting Evidence

The options market is pricing a smaller move than historical averages, indicating a potential mispricing of volatility.

Cencora has a high EPS beat rate of 88%, suggesting a strong likelihood of exceeding expectations.

Recent operational improvements may not be fully reflected in current market sentiment.

Key Risk

If the EPS comes in above $4.85, it could significantly shift market sentiment in favor of the company.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal for Cencora, as it seeks to regain investor trust after recent earnings misses.

Bull Confirmed If

An EPS of $4.85 or higher would confirm the bull case and suggest a strong recovery in profitability.

Bear Confirmed If

An EPS below $4.50 would confirm the bear case and raise concerns about ongoing operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing a relatively small move in the stock, suggesting that investors are uncertain about significant changes in either direction.

Options are pricing a 0.94% move while the stock has averaged a 5.6% move historically, indicating a potentially undervalued setup.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing cheap setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

History suggests that if Cencora beats EPS expectations, the stock could rise by an average of +0.61%, confirming a positive turnaround.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting ongoing uncertainty about future growth.

Miss

If the company misses expectations, history indicates a potential drop of -17.38%, signaling deeper concerns about its operational efficiency.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Details on revenue growth in key segments.
3Management's outlook on market conditions and competitive landscape.
4Insights into customer demand trends and product offerings.
5Comments on cost management strategies and margin expectations.